IL1B and Insulin resistance: Chronic inflammation resulting from GD-induced increases in the levels of inflammatory factors, such as IFN-γ, IL-1β, and TNF-α in vivo, may contribute to insulin resistance and increase the risk of developing T2D by affecting insulin sensitivity.